Home NDC 0603-3508 Effervescent Potassium Chloride
Product NDC 0603-3508
11-digit product format 006033508
Labeler code 0603
Product ID 0603-3508_71ebe1c1-4b74-9cab-e053-2a95a90a90ed
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Potassium Bicarbonate and Potassium Chloride Effervescent Tablets for Oral Solution
Dosage form TABLET, EFFERVESCENT
Route ORAL
Labeler Qualitest Pharmaceuticals
Marketing category UNAPPROVED DRUG OTHER
Marketing start 2006-01-06
Marketing end 2021-07-31
Substance POTASSIUM CHLORIDE; POTASSIUM BICARBONATE; LYSINE HYDROCHLORIDE
Active strength 1 g/1; g/1; g/1
Pharmacologic classes Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0603-3508-16 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0603-3508-16 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0603-3508-16 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0603-3508-16 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0603-3508-16 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0603-3508-16 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0603-3508-16 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0603-3508-16 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0603-3508-16 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0603-3508-16 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0603-3508-16 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0603-3508-16 557ba5c1ecfa…9c80585c8c6e…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded LYSINE HYDROCHLORIDE ACTIVE INGREDIENT JNJ23Q2COM EFFERVESCENT POTASSIUM CHLORIDE (POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE EFFERVESCENT TABLETS FOR ORAL SOLUTION) TABLET, EFFERVESCENT [QUALITEST PHARMACEUTICALS] 3 POTASSIUM BICARBONATE ACTIVE INGREDIENT HM5Z15LEBN EFFERVESCENT POTASSIUM CHLORIDE (POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE EFFERVESCENT TABLETS FOR ORAL SOLUTION) TABLET, EFFERVESCENT [QUALITEST PHARMACEUTICALS] 3 POTASSIUM CHLORIDE ACTIVE INGREDIENT 660YQ98I10 EFFERVESCENT POTASSIUM CHLORIDE (POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE EFFERVESCENT TABLETS FOR ORAL SOLUTION) TABLET, EFFERVESCENT [QUALITEST PHARMACEUTICALS] 3 BICARBONATE ION ACTIVE MOIETY HN1ZRA3Q20 EFFERVESCENT POTASSIUM CHLORIDE (POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE EFFERVESCENT TABLETS FOR ORAL SOLUTION) TABLET, EFFERVESCENT [QUALITEST PHARMACEUTICALS] 3 CHLORIDE ION ACTIVE MOIETY Q32ZN48698 EFFERVESCENT POTASSIUM CHLORIDE (POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE EFFERVESCENT TABLETS FOR ORAL SOLUTION) TABLET, EFFERVESCENT [QUALITEST PHARMACEUTICALS] 3 LYSINE ACTIVE MOIETY K3Z4F929H6 EFFERVESCENT POTASSIUM CHLORIDE (POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE EFFERVESCENT TABLETS FOR ORAL SOLUTION) TABLET, EFFERVESCENT [QUALITEST PHARMACEUTICALS] 3 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP EFFERVESCENT POTASSIUM CHLORIDE (POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE EFFERVESCENT TABLETS FOR ORAL SOLUTION) TABLET, EFFERVESCENT [QUALITEST PHARMACEUTICALS] 3 POLYETHYLENE GLYCOL 8000 INACTIVE INGREDIENT Q662QK8M3B EFFERVESCENT POTASSIUM CHLORIDE (POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE EFFERVESCENT TABLETS FOR ORAL SOLUTION) TABLET, EFFERVESCENT [QUALITEST PHARMACEUTICALS] 3 SACCHARIN SODIUM ANHYDROUS INACTIVE INGREDIENT I4807BK602 EFFERVESCENT POTASSIUM CHLORIDE (POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE EFFERVESCENT TABLETS FOR ORAL SOLUTION) TABLET, EFFERVESCENT [QUALITEST PHARMACEUTICALS] 3 SODIUM BENZOATE INACTIVE INGREDIENT OJ245FE5EU EFFERVESCENT POTASSIUM CHLORIDE (POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE EFFERVESCENT TABLETS FOR ORAL SOLUTION) TABLET, EFFERVESCENT [QUALITEST PHARMACEUTICALS] 3 SORBITOL INACTIVE INGREDIENT 506T60A25R EFFERVESCENT POTASSIUM CHLORIDE (POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE EFFERVESCENT TABLETS FOR ORAL SOLUTION) TABLET, EFFERVESCENT [QUALITEST PHARMACEUTICALS] 3
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0603-3508-16 00603350816 30 TABLET, EFFERVESCENT in 1 BOX (0603-3508-16) 2006-01-06 2021-07-31 No No Current